Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria.

Yoon S, Jin BH, Kim CO, Park K, Park MS, Chae D

Open source

DOI
10.3390/pharmaceutics16030334
Published
2024 Feb 27
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics16030334,
  title = {Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria.},
  author = {Yoon S and Jin BH and Kim CO and Park K and Park MS and Chae D},
  year = {2024},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics16030334},
  url = {https://doi.org/10.3390/pharmaceutics16030334}
}

RIS

TY  - JOUR
TI  - Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria.
AU  - Yoon S
AU  - Jin BH
AU  - Kim CO
AU  - Park K
AU  - Park MS
AU  - Chae D
PY  - 2024
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics16030334
UR  - https://doi.org/10.3390/pharmaceutics16030334
ER  - 

APA

S, Y., BH, J., CO, K., K, P., MS, P., & D, C. (2024). Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics16030334

Source records